Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
03/07/2014 | 16h14 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
25/06/2014 | 22h46 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
25/06/2014 | 22h40 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
25/06/2014 | 22h35 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
25/06/2014 | 22h31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
25/06/2014 | 22h12 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
25/06/2014 | 22h11 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
25/06/2014 | 22h05 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
25/06/2014 | 21h52 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
25/06/2014 | 21h49 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
25/06/2014 | 21h49 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
25/06/2014 | 21h44 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
25/06/2014 | 21h42 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
25/06/2014 | 21h39 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
24/06/2014 | 12h01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
23/06/2014 | 22h48 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
23/06/2014 | 22h35 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
23/06/2014 | 22h13 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
19/06/2014 | 22h47 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
19/06/2014 | 22h34 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
19/06/2014 | 22h30 | GlobeNewswire Inc. | NORTHERA(TM) Clinical Trial Data Published in Neurology | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
12/06/2014 | 13h30 | GlobeNewswire Inc. | Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson's Disease and Move... | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
11/06/2014 | 22h13 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
06/06/2014 | 23h10 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
06/06/2014 | 22h28 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
06/06/2014 | 13h00 | GlobeNewswire Inc. | Chelsea Therapeutics Announces the Expiration of the Hart-Scott-Rodino Waiting Period in Relation to the Proposed Acquisition... | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
02/06/2014 | 21h32 | PR Newswire (US) | The Law Office of Robbins Arroyo LLP Announces Class Action Lawsuit Against Chelsea Therapeutics International, Ltd. | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
28/05/2014 | 21h26 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
23/05/2014 | 22h54 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
23/05/2014 | 22h16 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |